Main Business
Domestic pharmaceutical development
Medical product development registration, prescription drug-to-OTC conversion technical services, bioequivalence evaluation services, government affairs support, and expert matchmaking.
International Pharmaceutical Development and Introduction
Sourcing and developing high-quality pharmaceutical products (drugs + devices) from overseas, domestic market entry development and registration, post-marketing pharmacovigilance, and acting as the China agent for foreign MAHs.
Participate in the innovation of foreign pharmaceuticals.
Participate in the early-stage development of original pharmaceutical products from overseas and engage in international cooperation on innovative pharmaceuticals.
In-depth market development
Obtain market access rights for pharmaceuticals, medical devices, and health products in the Chinese market and carry out in-depth market development.
International trade
Import of health foods, cosmeceuticals, and daily chemical products; cross-border e-commerce cooperation
Investment Cooperation
Promote China's outstanding pharmaceutical products and technologies to the international market.
Product Center
SINCE 2020
Creating value for customers, serving human health.
Rico International (Beijing) Medicine Technology Co., Ltd. was renamed and established in 2020; it is composed of a group of medical experts, scholars and senior management talents who have made achievements and contributions in the field of medicine and health. Our Aim is to assist domestic and foreign pharmaceutical companies in product introduction, technology introduction, market expansion and other cooperation; to introduce the world's best medical and health products and technologies to China to benefit the Chinese people; at the same time, to export Chinese high-quality medical and health products and technologies to foreign countries to benefit the whole human being.
Rico International (Beijing) Medicine Technology Co., Ltd., its predecessor was one of the stock companies of the former Ministry of Health Service Center. The company is now registered in Beijing and has an office in Tokyo, Japan.
Business objective: To provide a full range of solutions for the international application of excellent pharmaceutical products and new technologies; to become a pioneer in the international pharmaceutical market. The company is actively committed to introducing excellent foreign medicine and health products to China; at the same time, it also promotes China's excellent medicine and technology to the international market.
News Center
Our business objective: To provide solutions that facilitate the entry of international pharmaceuticals and new technologies into the Chinese market, and to promote the internationalization of China’s pharmaceuticals and technologies.
Business Cooperation
Sunflower Pharmaceutical
Tibet Hai Rong
Harbin Pharmaceutical Group
Napeptide Pharmaceutical
Yabao Pharmaceutical
Zhenbao Island Pharmaceutical
Laimi Pharmaceutical
Tianjin Institute of Pharmaceutical Research
Kangsen Pharmaceutical
Shanghai Pharmaceuticals
Yangtze River Pharmaceutical Group
Luo Xin Pharmaceutical